Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471260 | SCV000542570 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-03-02 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000518703 | SCV000616180 | uncertain significance | not provided | 2017-09-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000518703 | SCV001800975 | likely benign | not provided | 2020-12-31 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002365596 | SCV002661661 | uncertain significance | Cardiovascular phenotype | 2019-05-29 | criteria provided, single submitter | clinical testing | The p.R22177C variant (also known as c.66529C>T), located in coding exon 166 of the TTN gene, results from a C to T substitution at nucleotide position 66529. The arginine at codon 22177 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000518703 | SCV003824271 | uncertain significance | not provided | 2019-03-14 | criteria provided, single submitter | clinical testing |